CD4 and myeloid sarcoma: As shown in Figure 5A, SLE‐MS group exhibited a higher expression of IFN‐γ in the supernatant of CD4+ T cells (7376 ± 587.88 pg/mL), compared with HCs (3306 ± 782.91 pg/mL; p < 0.001).